NewYork Presbyterian Hudson Valley Hospital
Cortlandt Manor, New York, 10567, United States
NCT Number: NCT06079853
The purpose of this study is to identify factors (sleep, psychiatric characteristics, stressful life events, and work environment characteristics) that potentiate or mitigate adverse effects of real-world stressors that predispose nurses to suicidal risk.
The specific aims are:
Aim 1. To investigate associations between sleep, stressful life events (life stressors, discrimination, lateral violence), psychiatric characteristics (psychiatric diagnosis, subjective mood), work environment characteristics (workload, shift type and duration, overtime, nurse work environment, and team relations) and stress (self-report and heart rate variability) in working nursing professionals while controlling for standard covariates known to influence stress.
Aim 2. To determine if stress exposure (self-report and HRV) is associated with predisposing factors (sleep, stressful life events, additional psychiatric characteristics, and work environment characteristics), and to explore whether stress mediates the effect of predisposing factors on suicidal ideation in working nursing professionals.
Exploratory Aim. To explore the preliminary impact of an existing sleep intervention (sleep health promotion kit) on self-reported stress, HRV, sleep, and psychiatric health outcomes including depression, burnout, and suicidal ideation.
This record will focus on the Exploratory Aim.
Looking for future studies?
Notify Me21 year and older
All sexes
Interventional
Not applicable
Cortlandt Manor, New York, 10567, United States
Despite being the largest healthcare workforce in the United States (US) (~5 million nurses), evidence about suicidal ideation and predisposing factors that contribute to suicide in nurses is limited. Outside of nursing, there is substantial evidence that an individual's psychiatric characteristics (psychiatric diagnosis; decision-making; social cognition; mood) and/or life stressors (e.g., death of a loved one, divorce, discrimination, or lateral violence) are significantly associated to suicidal ideation. Yet, it is unclear why nurses have higher rates of suicide compared to other populations and which factors predispose nurses to higher risk for suicidal behavior. It has become critical to test new approaches to reduce stress in nurses and subsequently mitigate suicide ideation. There is early evidence that sleep disturbances may induce increased stress and subsequently higher psychological risk, including depression, a known predisposing risk factor for suicidal risk. Evidence about the associations between sleep and suicidal ideation is limited but early studies show promise that interventions promoting sleep health may help mitigate suicidal risk. The isolation of predisposing factors for stress in nurses and investigation of potential interventions to counteract such stress may help to identify and mitigate suicide risk in nurses. Past evidence about suicide has been limited to post-mortem data inhibiting an understanding of which personal, psychosocial, and work environment factors predispose a nurse to suicidal behaviors. The combined study of self-report and physiologic data may help us better understand sources of stress adaptation in the search for underlying biological mechanisms associated with suicide and other suboptimal psychologic health outcomes.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
PureSomni sleep health products offered: blue light blocking glasses, eye mask, nasal strips, white noise machine, lavender spray, herbal tea, ear plugs
Time frame: Baseline: Week 1
This outcome measures the number of participants who had a score greater than 0 on the CSSRS at Baseline (Week 1).
CSSRS total score range is from 0-6, with the higher number indicating more intense ideation. Any score above 0 indicates a positive ideation in the past month.
Time frame: Follow-up: Week 4
This outcome measures the number of participants who had a score greater than 0 on the CSSRS at Follow-up (Week 4).
CSSRS total score range is from 0-6, with the higher number indicating more intense ideation. Any score above 0 indicates a positive ideation in the past month.
Time frame: Follow-up: Week 8
This outcome measures the number of participants who had a score greater than 0 on the CSSRS at Follow-up (Week 8).
CSSRS total score range is from 0-6, with the higher number indicating more intense ideation. Any score above 0 indicates a positive ideation in the past month.
Time frame: 8 weeks
Participants will wear the OuraRing to capture physiologic continuous heart rate variability. Heart rate variability is the variance in time between heart beats (RR intervals on an EKG) and is calculated using root mean square of successive differences between heartbeats. The middle 50% of 20-25 year olds usually have an average HRV in the 55-105 range, while 60-65 year olds tend to be between 25-45. In general, a higher heart rate variability is considered better as it indicates a more adaptable and resilient autonomic nervous system, which can respond effectively to different stressors. We calculated the mean difference between the control time period (Week1-4) and the intervention time period (Week 5-8).
Time frame: baseline-Week 1
Scaling: Self reported Survey Instrument Range: 0 to 21 Interpretation: A global sleep score over 5 indicates poor sleep quality.
Time frame: Follow up- Week 4
Scaling: Self reported Survey Instrument Range: 0 to 21 Interpretation: A global sleep score over 5 indicates poor sleep quality.
Time frame: Follow up- Week 8
Scaling: Self reported Survey Instrument Range: 0 to 21 Interpretation: A global sleep score over 5 indicates poor sleep quality.
Time frame: 8 weeks
This is to measure the average amount of daily sleep (hours) over an 8 week period. The physiologic data is collected via a wearable device (OuraRing).
We calculated the mean difference in sleep duration (hours) between Week 1-4 (Control time period) and Week 5-8(Intervention time period).
Time frame: 8 Weeks
Total number of participants with at least 1 suicidal behavior that occurred during the given time period of 8 weeks.
Time frame: Baseline- Week 1
Scaling - Self report survey (subscale 1-emotional exhaustion) 7 point Likert Scale; Score Range 0-42
Interpretation:
17 or less - Low level of burnout 18-29 - Moderate level of burnout Greater than 30 - High level of burnout
Time frame: Baseline- Week 1
Scaling - Self report survey (subscale 2-Depersonalization) 7 point Likert Scale; Score Range 0-42
Interpretation:
5 or less - Low level of burnout 6-11 - Moderate level of burnout Greater than 12 - High level of burnout
Time frame: Baseline- Week 1
Scaling - Self report survey (subscale 3-Personal Achievement) 7 point Likert Scale; Score Range 0-48
Interpretation:
33 or less - Low level of burnout 34-39 - Moderate level of burnout Greater than 40 - High level of burnout
Time frame: Week 8
Scaling - Self report survey (subscale 1-emotional exhaustion) 7 point Likert Scale; Score Range 0-42
Interpretation:
17 or less - Low level of burnout 18-29 - Moderate level of burnout Greater than 30 - High level of burnout
Time frame: Week 8
Scaling - Self report survey (subscale 2-Depersonalization) 7 point Likert Scale; Score Range 0-42
Interpretation:
5 or less - Low level of burnout 6-11 - Moderate level of burnout Greater than 12 - High level of burnout
Time frame: Week 8
Scaling - Self report survey (subscale 3-Personal Achievement) 7 point Likert Scale; Score Range 0-48
Interpretation:
33 or less - Low level of burnout 34-39 - Moderate level of burnout Greater than 40 - High level of burnout
Columbia University
Other
The Use of Physiologic Measures and Sleep Health Promotion to Identify and Mitigate Predisposing Factors of Suicidal Ideation in Nurses
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03868930
Anxiety Disorders, Behavior
Boston, Massachusetts, United States
View Trial DetailsNCT04506164
Behavior, Behavioral Symptoms
San Diego, California, United States
View Trial DetailsNCT03543865
Behavior, Behavioral Symptoms
Whiteriver, Arizona, United States
View Trial DetailsNCT04343703
Behavior, Behavioral Symptoms
Seville, Andalusia, Spain
View Trial Details